Skip to main content
Be The Investor
Home›Stocks›MDLN
MDLN

Medline Inc.

MDLN
NASDAQUnited States flagUSReal-Time Price
$33.69USD
-0.40 (-1.17%)Today
$33.69-0.00 (-0.01%)After Hours7:56 PM ET
BTI Score

BASIC required or higher

View pricing
BTI Fair Market Cap
$41.16B
-28.19% vs fair
Healthcare & Pharma
Buy

Medline Inc. (MDLN) Stock Overview

Medline Inc. (MDLN) is a Healthcare company in the Medical - Instruments & Supplies industry listed on NASDAQ. Review available quotes, BTI valuation, financial statements, earnings, news and risk information.

Market Cap
$29.56B
Enterprise Value
$39.87B
Volume
8.13M
Avg. Volume
7.88M
P/E (TTM)
64.67
Forward P/E
22.64
EPS (TTM)
$0.86
Profit Margin
2.31%
FCF Margin
+6.77%
Dividend Yield
0.00%
Beta
-0.41
52 Week Range
$31.49$50.88
Next Earnings
2026-11-04
Time TBD
Investor Snapshot
Analyst Consensus
Strong Buy
Based on 34 analysts
🟢 Buy 27
🟡 Hold 7
🔴 Sell 2
Average Price Target
$44.31
+31.52% Upside
High $55.00Low $34.00
Expected Upside
+31.52%
From current price
Valuation Status
Fair Value
Justified
UndervaluedOvervalued
Risk Level
Moderate

MDLN Price Chart

Trend:
Momentum:
Volatility:
Volume:

Analyst Insights

Strong Buy
Based on 34 analysts
Buy27
Hold7
Sell2

Earnings Trends

Earnings Per Share

↗

Revenue Beat Rate

100%
Beat Rate
Beat3
Meet0
Miss0
Total3
↗

EPS Beat Rate

100%
Beat Rate
Beat3
Meet0
Miss0
Total3
★

Analyst Expectations

75%
Positive
Above27
In-Line7
Below2
Total36

Quarterly EPS Performance

Recent results and upcoming quarter
Q1 FY26
31 / 03 / 2026
Beat
Estimate$0.30Actual$0.33Surprise+$0.03 (+9.49%)
Q2 FY26
30 / 06 / 2026
Beat
Estimate$0.33Actual$0.50Surprise+$0.17 (+52.21%)
Q3 FY26
30 / 09 / 2026
Upcoming
Estimate—Actual—Surprise—
Q4 FY26
04 / 11 / 2026
Upcoming
Estimate$0.34Actual—Surprise—

Quarterly Revenue Performance

Actual quarterly revenue with consensus when available
Q4 FY25
31 / 12 / 2025
beat
Estimate$7.52BActual$7.79BSurprise$268.35M (+3.57%)
Q1 FY26
31 / 03 / 2026
beat
Estimate$0Actual$7.35BSurprise$7.35B
Q2 FY26
27 / 06 / 2026
beat
Estimate$0Actual$7.68BSurprise$7.68B
Q4 FY26
04 / 11 / 2026
upcoming
Estimate$7.72BActual—Surprise—

Revenue vs Earnings Over Time

Revenue (B USD)Net Income (B USD)Profit Margin (%)
FY22FY23FY24FY25FY2608162432-2%0%2%4%6%-0.1%1%4.7%4.1%2.3%
Source: Yahoo Finance quarterly financialsYoY comparison
MDLN upcoming earnings call
2026-11-04 at 4:30 PM EST
Coming SoonTime TBD

Earnings Call Hub

Listen live or replay earnings calls with AI-powered insights.

Coming SoonTime TBD
MDLN upcoming earnings call
2026-11-04
Reminder via

AI Call Summary

Beta

MDLN is expected to report results shaped by demand trends, margin performance and management guidance. Investors should watch earnings quality, cash flow and outlook commentary.

Call Agenda

Revenue Review
Guidance & Outlook
Data Center Update
HBM Growth
NAND Market
Q&A Session

Recent News

No relevant recent news available for this stock.

Company Overview

MDLN
CEO
James Boyle
Founded
2025
Employees
45,000
Headquarters
Northfield, IL
Industry
Medical - Instruments & Supplies